Stabilized recombinant hantaviral spike proteins comprising mutations in Gc

Abstract

The present invention describes specific engineering of the hantavirus spike proteins with modifications to stabilize (Gn/Gc).sub.n heterodimer contacts and/or Gc homodimer contacts and/or Gn/Gn oligomer contacts on the spike with the purpose of using them as immunogens in next-generation vaccine design. Said spike proteins have been covalently stabilized by at least one disulphide inter-chain bond between Gn/Gc heterodimers and/or between Gc homodimers and/or between Gn homo-oligomers as they are presented at the surface of infectious virions. It also involves spike stabilization by introduction of cavity-filling amino acids with a bulky side chain at the above-mentioned contacts. Said spike proteins can be soluble Gn/Gc ectodomains in solution and/or incorporated as (Gn/Gc).sub.n hetero-oligomers onto virus-like particles (VLPs) and/or used for pseudotyping virus vectors and/or form part of a stabilized recombinant virus, wherein said spike proteins can be used to select ligands and/or can be used for preventing or treating infections by one or more hantaviruses.

Claims

1. A stabilized hantaviral spike comprising at least one homodimer of Gc mutants, the at least one homodimer of Gc mutants comprising first and second polypeptide chains, each of the first and second polypeptide chains having an amino acid sequence that comprises the amino acid sequence of the Gc of SEQ ID NO: 1 at positions 652-1138 but with at least one amino acid substitution at a position determined when each of the first and second polypeptide chains is aligned with the Gc of SEQ ID NO: 1, wherein the at least one amino acid substitution in each of the first and second polypeptide chains is selected from the group consisting of: the substitution G838C that results in the Gc mutant sequence of SEQ ID NO: 2, the substitution T839C that results in the Gc mutant sequence of SEQ ID NO: 3, the substitution H953C that results in the Gc mutant sequence of SEQ ID NO: 4, and the substitution H953F that results in the Gc mutant sequence of SEQ ID NO: 5.

2. The stabilized hantaviral spike according to claim 1, wherein each polypeptide chain of the at least one homodimer of Gc mutants has the substitution G838C, wherein the amino acid residues 838C of the respective polypeptide chains are linked together through a disulphide inter-chain bond.

3. The stabilized hantaviral spike according to claim 1, wherein each polypeptide chain of the at least one homodimer of Gc mutants has the substitution T839C, wherein the amino acid residues 839C of the respective polypeptide chains are linked together through a disulphide inter-chain bond.

4. The stabilized hantaviral spike according to claim 1, wherein each polypeptide chain of the at least one homodimer of Gc mutants has the substitution H953C, wherein the amino acid residues 953C of the respective polypeptide chains are linked together through a disulphide inter-chain bond.

5. The stabilized hantaviral spike according to claim 1, wherein each polypeptide chain of the at least one homodimer of Gc mutants has the substitution H953F.

6. The stabilized hantaviral spike according to claim 1, wherein each polypeptide chain of the at least one homodimer of Gc mutants has a double substitution Q844C/H953C, wherein the amino acid residues 844C and 953C are linked respectively to the amino acid residues 844C and 953C through a disulphide inter-chain bond.

7. A stabilized hantaviral spike comprising at least one heterodimer of Gn/Gc mutants comprising a mutant Gn monomer and a mutant Gc monomer, wherein the mutant Gn monomer comprises the amino acid sequence of the Gn of SEQ ID NO: 1 at positions 1-651 but with at least one amino acid mutation (substitution) selected from the group consisting of: H294C, R281C, T99C, K85C, N94C and a combination thereof; and wherein the mutant Gc monomer comprises at least one amino acid mutation (substitution) selected from the group consisting of: T734C, P748C, P774C, V776C and a combination thereof, the positions of the substitutions being determined by alignment with SEQ ID NO: 1.

8. The stabilized hantaviral spike according to claim 7, which comprises the at least one heterodimer with the mutant Gn monomer having the substitution H294C and the mutant Gc monomer having the substitution T734C, wherein the amino acid residues 294C and 734C of the respective mutant Gn monomer and mutant Gc monomer are linked together through a disulphide inter-chain bond.

9. The stabilized hantaviral spike according to claim 7, which comprises the at least one heterodimer with the mutant Gn monomer having the substitution R281C and the mutant Gc monomer having the substitution P748C, wherein the residues 281C and 748C are linked together through a disulphide inter-chain bond.

10. The stabilized hantaviral spike according to claim 7, which comprises the at least one heterodimer with the mutant Gn monomer having the substitution T99C and the mutant Gc monomer having the substitution P774C, wherein the residues 99C and 774C are linked together through a disulphide inter-chain bond.

11. The stabilized hantaviral spike according to claim 7, which comprises the at least one heterodimer with the mutant Gn monomer having the substitution K85C and the mutant Gc monomer having the substitution P774C, wherein the residues 85C and 774C are linked together through a disulphide inter-chain bond.

12. The stabilized hantaviral spike according to claim 7, which comprises the at least one heterodimer with the mutant Gn monomer having the substitution N94C and the mutant Gc monomer having the substitution V776C, wherein the residues 85C and 774C are linked together through a disulphide inter-chain bond.

13. A stabilized hantaviral spike, which comprises at least one homooligomer comprising a first Gn mutant subunit and a second Gn mutant subunit, each of the first and second Gn mutant subunits having a double substitution E61C/Q200C, wherein positions of the substitutions are determined by alignment with SEQ ID NO: 1, wherein the amino acid residues 61C and 200C of the first Gn mutant subunit are linked respectively to the amino acid residues 61C and 200C of the second Gn mutant subunit through disulphide inter-chain bonds between the first and second Gn mutant subunits.

14. A kit comprising the stabilized hantaviral spike according to claim 1 and a vector selected from the group consisting of an envelope of a recombinant virus, a pseudotype virus vector, and a virus-like particle.

Description

BRIEF DESCRIPTION OF FIGURES

(1) FIG. 1. Secondary structure elements of the hantaviral spike structure.

(2) Multiple sequence alignment of the Gn/Gc proteins of pathogenic hantaviruses compared to hantaviruses harbored in insectivores. FIG. 1 shows the amino acid sequences for hantavirus isolates ANDV (SEQ ID NO:1); SNV (SEQ ID NO: 13); PUUV (SEQ ID NO:14); DOBV (SEQ ID NO:15); HNTV (SEQ ID NO: 16); SEOV (SEQ ID NO: 17); LOQV (SEQ ID NO: 18) and ASAV (SEQ ID NO: 19). The Gn/Gc glycoproteins are synthesized as glycoproteins precursor that is cleaved by a host protease into the N-terminal Gn and the C-terminal Gc glycoproteins, at the signal sequence “WAASA”. Strictly conserved and highly similar residues are highlighted in grey. The secondary structure elements obtained from the Gn/Gc crystal structure of Andes virus are displayed above the sequences. For regions missing structural information (to be included). Disulfide bonds are indicated with light grey numbers below the sequence alignment.

(3) FIG. 2. The structure of hantavirus Gc and identification of Gc/Gc homodimer contacts.

(4) A) Top view of the Hantaan virus Gc homodimer structure. To improve visibility, the human single-chain variable domain (scFv) antibody was removed from the Gc/scFv A5 structure complex. One Gc protomer is highlighted in black, while the other is indicated in grey. B) Side view of the Gc homodimer structure. C) Insert showing the Gc/Gc homodimer contacts where the different regions forming the contacts are highlighted. D) Multi-angle light scattering (MALS) of the soluble Gc ectodomain of Hantaan virus used to obtain the Gc crystal structure.

(5) FIG. 3. The structure of hantavirus Gn/Gc heterodimer and identification of Gn/Gc heterodimer contacts.

(6) A) Side view of the Andes virus Gn/Gc heterodimer structure. The Gn protomer is indicated in white, the Gc protomer in black. B-D) Inserts showing the different Gn/Gc contacts in which the different regions forming the contacts are highlighted.

(7) FIG. 4. Fitting of the Gn/Gc structure into the Tula hantavirus Cyro-ET map and identification of Gn/Gn contacts.

(8) A) Top view of four Gn/Gc heterodimer structures fitted into the available Cryo-ET map for the Tula hantavirus spike (Shi et al., 2016). Gn is indicated in white, Gc is indicated in black. B) Side view of two Gn/Gc heterodimers fitted into the spike density of the Tula hantavirus Cryo-ET map. C) Insert showing different Gn/Gn contacts in which the different regions forming the contacts are highlighted.

(9) FIG. 5. Characterization of Gn/Gc mutants expression and of their assembly into VLPs bearing the engineered disulfide bonds.

(10) (A-B) Characterization of the expression yields and cellular localization of ANDV Gn and Gc proteins that comprise either single mutation at the Gc homodimer interface (A), or double mutations at the Gc homodimer interface, or double mutations at the Gn/Gc interface of the Gn/Gc spikes (B). Western blot analysis using anti-Gc or anti-β-actin MAbs of different cellular fractions obtained from 293FT cells expressing wild type (wt) or mutant Gn/Gc after cell surface biotinylation. The fractions correspond to the non-biotinylated fraction (intracellular proteins) or the biotinylated fraction (surface proteins). C) SDS Page and western blot under reducing and non-reducing conditions of VLPs bearing wt or mutant Gn/Gc spikes comprising single or double cysteine substitutions at the Gc homodimer interphase. using anti-Gc antibody. D) SDS Page and western blot under reducing and non-reducing conditions of VLPs bearing wt or mutant Gn/Gc spikes comprising double cysteine mutations at the Gn/Gc heterodimer interface: H294C/T734C, R281C/P748C, T99C/P744C, K85C/P774C or N94C/V776C using either anti-Gc (left panel) or anti-Gn specific antibodies (right panels). VLPs bearing wt Gn/Gc spikes were used as a negative control for disulfide bond formation, while VLPs bearing Gn/Gc spikes comprising the single mutant G838C at the Gc homodimer interface was used as a positive control for disulfide bond formation of Gc homodimers.

(11) FIG. 6. Acid stability of wt and mutant hantaviral spikes.

(12) A) Liposome co-flotation assay to visualize acid-induced activation and membrane insertion of VLPs bearing wt Gn/Gc spikes or Gn/Gc spikes comprising the single mutation H953F at the Gc homodimer interface. VLPs were incubated with liposomes at different pHs at 37° C. and the mixture was floated on a step gradient. Fractions taken consecutively from the bottom of the step gradient were examined for the presence of VLPs western blot using anti-Gc MAb. B) Quantification of the presence of wt and mutant VLPs in the fractions of the co-flotation assay. Results from at least n=3 independent experiments were averaged.

(13) FIG. 7. Thermal stability of wt and mutant detergent-solubilized hantaviral spikes.

(14) A-B) The Oligomeric state of the detergent-solubilized hantaviral spikes at different temperatures. Blue native-PAGE and western blot analysis of detergent solubilized VLPs displaying wt or mutant spikes including single Gc mutants at the Gc:Gc interface (A) or double mutations at the Gn/Gc interface (B). The spikes were extracted from VLPs by Triton X-100 and treated at the indicated temperatures of 20-60° C. at neutral pH. The presence of Gn or Gc in each lane was detected by western blot analysis by splitting the transferred gel in two parts and revealing with anti-Gn (left panel) and anti-Gc (right panel) antibodies. As internal control for Gc species migration, Gc wt homotrimers were examined in each gel by treatment of VLPs at pH 5.5. To further estimate the oligomerization species of Gn and Gc (indicated on the left side of the blot), the migration of their monomeric and multimeric forms was compared with a native protein standard (indicated on the right side of the blot). (C-E) Graph of the temperature-induced Gn/Gc dissociation of detergent solubilized spikes quantified by densitometry from wt, or (C) mutants at the Gc homodimer interface that do not improve the spike stability, (D) the Gc mutant G838C at the Gc homodimer interface and (E) Gn/Gc mutants at the Gn/Gc interface. Averages±s.d. are shown. The curves were fitted using a sigmoidal equation. The melting temperature (Tm) of the detergent-solubilized spikes is indicated for each mutant.

(15) FIG. 8. Exposure of the Gc fusion loop of wt and mutant hantaviral spikes.

(16) (A) Liposome co-flotation assay to determine the exposure of the Gc fusion loops and their insertion into membranes. VLPs were incubated with liposomes at different temperatures and pHs and the mixture floated on a step gradient and the presence of VLPs examined in each fraction by western blot using anti-Gc MAb. The double Gc fusion loop mutant W766A/F901A, that does not insert into target membranes was used as negative control. (B) Fusion loop exposure temperature compared to the melting temperature of wt Gn/Gc spikes versus mutant spikes assembled onto VLPs. The quantification of the fraction of Gc interacting with liposomes at different temperatures, superimposed to the fraction of dissociated Gc at the same temperatures. Results from at least n=3 independent experiments were averaged.

(17) FIG. 9. Neutralizing antibody responses against VLPs bearing wild type or mutant hantaviral spikes in mice.

(18) (A-B) Neutralizing activity of sera from Balb/c mice after the immunizations with VLPs bearing wt or mutant hantaviral spikes comprising either the single mutant G838C at the Gc homodimer interface (A) or comprising the double mutation H294C/T734C at the Gn/Gc heterodimer interface. Neutralization of Andes virus was assessed through incubation of ANDV with sera from mice for 1 hr and subsequent adsorption to Vero E6 cells that were immunized with VLPs bearing wt or mutant hantaviral spikes. As a control, sera of mice immunized with VLPs bearing wt Gn/Gc were used as well as sera from mice before immunization. Infection was quantified by flow cytometry 16 h post-infection using anti-ANDV nucleoprotein antibody.

EXAMPLES

Example 1. The Selection and Design of Amino Acid Modifications for Improved Stability of the Hantaviral Spike

(19) In order to face the technical challenge to improve the spike stability, for the generation of improved immunogens, we used structural information to identify and select key positions and regions in the hantaviral spikes that allow the design of sequence modifications for their stabilization.

(20) The molecular structures of the ectodomains of the hantavirus Gn and Gc proteins have been described in their monomeric conformations; however information was still missing concerning their orientation in the hantaviral spike and their molecular contacts for a molecular perspective on their assembly and the design of preventive or therapeutic strategies.

(21) In the present example, the inventors have obtained novel molecular structures that describe the contacts of the Gn/Gc assembly. Among these structures, two particular structures have been obtained from two different expression constructs stably transfected into Drosophila S2 cells: a) expression plasmid pMT-rGc-W115H coding the recombinant Gc ectodomain (rGc) (residues 652-1107) including the W115H mutation and two C-terminal strep-tag sequences separated by a (GGGS)3 linker preceded by an enterokinase cleave site as previously described (Guardado-Calvo et al., 2016). b) expression plasmid pMT-rGn-Gc coding for the recombinant Gn (rGn) (residues 21-374) and rGc (residues 652-1107) ectodomains connected by a 42 amino acids flexible linker region and two C-terminal strep-tag sequences separated by a (GGGS)3 linker preceded by an enterokinase cleave site as previously described (Guardado-Calvo et al., 2016).

(22) The expression products were purified and crystallized for subsequent X-ray diffraction by standard methods. In the case of rGc, we crystallized this protein by previous incubation with human single-chain variable domain (scFv) antibody fragment A5 as previously described (Guardado-Calvo et al., 2016).

(23) We determined the Gc crystal structure at 3.0 Å resulting in a Gc homodimer (FIG. 2) while we were able to reveal the Gn/Gc crystal structure at 2.7 Å (FIG. 3). The structures allowed us to identify the molecular contacts between the Gc/Gc homodimer and the Gn/Gc heterodimer. When we further fitted the Gn/Gc crystal structure into the available 16 Å resolution electron cryo-tomography reconstruction of Tula hantavirus (Shi et al., 2016), we could also define contacts of the Gn/Gn homooligomers (FIG. 4).

(24) In this context, we selected preferred amino acids for modifications by the following criteria: a) forming the contact interphase between the Gc/Gc homodimer, Gn/Gc heterodimer and Gn/Gn homooligomer. b) cavity filling mutants.

(25) Among these amino acids, we selected those for modifications that fulfilled at least one of the following criteria: a) The impact of the mutation in the structure to avoid protein missfolding. b) The conservation of the residue. c) The certainty of the residue position in the model based on the observed electron density. d) For the design of inter-chain bonds, the distances between the C.sub.alpha-C.sub.alpha atoms should be less than 6.5 Å and for C.sub.beta-C.sub.beta atoms less than 4.5 Å. e) For inter-chain disulfide bonds, the quality of the modeled disulphide bond is evaluated using the dihedral angles C.sub.i.sup.beta-S.sub.i-S.sub.j-C.sub.j.sup.beta, C.sub.i.sup.alpha-C.sub.i.sup.beta-S.sub.i-S.sub.j, and C.sub.j.sup.alpha-C.sub.j.sup.beta-S.sub.j-S.sub.i. f) For the design of cavity filling mutants, residues were selected with improved affinity score (improved ΔG) by Rosetta.

(26) To highlight the different selected amino acids, we refer to the Andes virus sequence nomenclature as identified in FIG. 1. However, since the structure and sequences of the glycoproteins is highly conserved between hantaviruses (Guardado-Calvo et al., 2016; Wilensky et al., 2016; Shi et al., 2016), the contacts that we observe in the Andes virus and Hantaan virus Gn/Gc structures, can be extended to any Gn/Gc protein of the Hantaviridae family.

(27) For the ease of understanding, we called each region as we could derive it from the secondary elements in the structure. If hence a region is contained in a beta strand, we termed this region following the strand nomenclature; e.g. “b strand”. When a region is contained between two beta strands, for example between beta strand b and c, we termed this region “bc linker” or “bc loop” according to its structural features.

(28) From these overall criteria, we selected the following possible amino acids for modifications. Among them, the amino acid modification can correspond to any amino acid substitution, including Ala, Leu, Val, Ile, Trp, Tyr, Phe, Pro, Met, Ser, Cys, Sec, Gly, Asn, Gin, Thr, Glu, Asp, His, Lys and/or Arg:

(29) (1) The Gc/Gc Homodimer

(30) The Gc/Gc homodimer contacts spanning amino acids comprised of the Gc strands B.sub.0 (residues 1676-P683), H.sub.0 (residues V832-V837), I.sub.0 (residues R951-L958) and the Hof linker region between strand H.sub.0 of Gc domain I and the f strand of Gc domain II comprising amino acids G838-D847. For clarity, please see FIG. 1 and FIG. 2.

(31) This list of amino acid regions resulted in the preferred amino acids: Gc E677, D679, G838, T839, S841, R951 and/or H953 and the contact pairs Gc E677/R951, D679/H953 and/or H953C/Q844C.

(32) In our preferred realization, the modifications correspond to Cys substitutions to form inter-chain disulfide bonds through the following amino acid substitutions: G838C, T839C, S841C/R951C, E677C/R951C, D679C/H953C and/or Q844C/H953C. A preferred cavity filling mutant includes H953F.

(33) (2) The Gn/Gc Heterodimer

(34) The Gn/Gc heterodimer contacts comprising (FIG. 1, FIG. 3):

(35) A) Any Gn amino acid from the helix 2-A.sub.B linker region and A.sub.B strand comprising residues N290-I297 in combination with any residue from the Gc a/b strand, comprising residues T729-H737.

(36) B) Any amino acid from the Gn D.sub.AE.sub.A loop comprising residues K85-T99 with any Gc amino acid either from the Gc cd loop comprising P774-T778, and/or from Gc bc loop comprising C738-Y747.

(37) C) Any amino acid from the Gn bc loop comprising H203-D206 in combination with any amino acid comprised by the Gc fg loop spanning residues G853-L855.

(38) This list of amino acid regions resulted in the preferred amino acids:

(39) Gn K85, N94, A95, T99, H203, D206, N290 and/or H294 and/or Gc T734, T729, P774, V776 Y739, P774, Gc L855 and/or P854. From those, we established the following contact pairs: Gn H294/Gc T734, Gn N290/Gc T729, Gn K85/Gc P774, Gn N94/Gc V776C, Gn A95/Gc Y739, T99/Gc P774, Gn H203/Gc L855 and/or Gn D206/Gc P854.

(40) In our preferred realization, the amino acid modifications correspond to Cys substitutions to form inter-chain disulfide bonds through the following amino acid substitutions: Gn H294C/Gc T734C, Gn N290C/Gc T729C, Gn K85C/Gc P774C, Gn N94C/Gc V776C, Gn A95C/Gc Y739C, T99C/Gc P774C, Gn H203C/Gc L855C and/or Gn D206C/Gc P854C.

(41) (3) The Gn/Gn Homooligomer

(42) The Gn/Gn homooligomer contacts, comprising (FIG. 1, FIG. 4):

(43) A) Any amino acid of the Gn be loop comprising residues P192-D206 of one Gn protomer in combination with any amino acid modification in the Gn region K59-Q75 comprising the CA strand and the region comprised between the CA strand and the DA strand in the other Gn protomer.

(44) This list of amino acid regions resulted in the preferred amino acids: Gn E61, Q200 From which we established the following contact pair: Gn E61/Q200.

(45) In our preferred realization, the amino acid modifications correspond to Cys substitutions to form inter-chain disulfide bonds through the following amino acids substitutions: E61C/Q200C.

(46) Based on the results shown in this example, we identified several key positions and regions that allowed the proposal of specific sequence modifications in such key positions and regions for the design of recombinant hantaviral spikes in order to improve their stability.

Example 2. Expression and Folding of Hantaviral Spike Mutants

(47) The present example of the invention provides information on how the inventors experimentally assess whether the design of recombinant hantaviral spikes are expressed and properly folded in cells.

(48) In this example we used the plasmid pl.18/GPC coding for the Gn/Gc glycoproteins of Andes orthohantavirus CHI-7913 isolate GenBank accession number AA086638.1 (Cifuentes-Muñoz et al., 2010) as a model for all hantaviral Gn/Gc coding plasmids and introduced nucleotide mutations using standard oligonucleotide-based PCR amplification technique.

(49) The expression and folding of each mutant construct was assessed by transient transfection of 293FT cells (Invitrogen) and subsequent biotinylation of cell surface proteins as previously described (Guardado-Calvo et al., 2016). The presence of the Gn/Gc proteins in the biotinylated (cell surface proteins) and non-biotinylated fractions (intracellular proteins) was tested by western blot using the MAb anti-Gc 2H4/F6. The empty pl.18 plasmid was used as negative control. In FIG. 5A the inventors show an example of Gn/Gc single mutants in which the Gc/Gc contacts were modified to stabilize or to weaken the hantaviral spikes. For these mutants the inventors found different expression levels, ranging from high expression levels (H953C, E677Q, R951Q, E677K, D679K, D679N, G838C) to low (D679A, D679S, H953D, R951E, H953E) and non-detectable (E677A, R951A, H953A) (FIG. 5A). The Gc mutants that we detected in the intracellular fraction trafficked all to the plasma membrane, confirming that they could exit the ER and enter the secretary pathway of the cell, a measure for proper protein folding (FIG. 5A, surface fraction). As example of the expression yields and cellular localization of double mutations in the hantavirus spike at the Gc/Gc or Gn/Gc heterodimer interfaces, the inventors used the same approach. Although expression yields were found to be lower in all cases compared to wt (FIG. 5B, intracellular fraction), most mutants were independently detected at the plasma membrane (Q844C/H953C, H294C/T734C, T99C/P774C, N294C/V776C) (FIG. 5B, surface fraction), confirming their proper folding and cell trafficking. Hence, these mutants can be used for further analysis of the hantaviral spike characterization and are candidate antigens for vaccine design or for the selection of antiviral compounds.

(50) With the above techniques, the inventors also introduced other amino acid modifications at additional residue positions. For the following residue substitutions the inventors obtained high expression levels and proper trafficking:

(51) Gc homodimer single mutant GcT839C and Gc double mutant Gc Q844C/Gc H953C.

(52) Gn/Gc heterodimer double mutants: Gn H294C/Gc T734C; Gn R281C/Gc P748C; Gn T99C/Gc P774C and Gn N94C/Gc V776C.

(53) Gn/Gn homodimer double mutants: Gn E61C/Q200C.

(54) To detect Gn mutant proteins, the by us well-established anti-Gn MAb 6B9/F5 was used.

(55) In this example, the Gn/Gc wt and mutant proteins were expressed in their full length and can be harvested from the cell supernatant in form of virus-like particles. Alternatively, those of skill in the art can also express the Gn/Gc proteins as soluble ectodomains in which the transmembrane anchors and stem regions have been removed as described in Example 1. Also, Gn/Gc proteins can be used to pseudotype virus vectors or to produce recombinant viruses as it has been well described in the field (Ray et al. 2009; Cifuentes-Muñoz et al., 2010; Kleinfelter et al., 2015).

(56) With the expressed Gn/Gc proteins, the inventors obtained well expressed recombinant hantavirus Gn/Gc proteins, that were incorporated onto virus-like particles.

Example 3. Assessment of Inter-Chain Disulfide Bonds in Hantaviral Spikes

(57) In this examples, the inventors provide evidence, that the Gn/Gc proteins that contain amino acid substitutions by Cys, are close enough on the viral particles to allow the formation of disulfide bonds across the different Gc/Gc and Gn/Gc interfaces.

(58) To improve the hantaviral Gc spike stability, we have designed several inter-chain disulfide bonds between Gc/Gc homodimers, Gn/Gc heterodimers and Gn/Gn homooligomers (see Example 1) based on the Gn/Gc and Gc/Gc crystal structures and Gn/Gc structure fitting into the Cryo-EM density map (Shi et al., 2016). Some inter-chain disulfide bonds may involve the substitution of single residues in each monomer (for example the substitutions Gc G838C) since in such case these residues are facing each other at the center of the 2-fold axes of the Gc homodimer. In other cases, we have designed a pair of Cys substitutions of residues that are opposing each other at any of the homodimer and/or heterodimer contact interphases to establish disulfide inter-chain bonds.

(59) By way of example, the following hantaviral Gc/Gc spike mutants have been used to functionally assay the formation of such inter-chain disulfide bonds; Gc single mutants G838C, T893C, and Gc H953C and Gc double mutant Q844C/H953C (FIG. 5C). Therefore, we concentrated the wt and mutant VLPs from 293FT cells expressing these mutants (FIG. 5A) and subjected them to SDS PAGE and western blot analysis under reduced and non-reduced conditions. In the case of the addition of p-Mercaptoethanol (reducing condition), we found that all mutants migrated as the wt Gc protein (.sup.˜50 kDa). However, in absence of a reducing agent, all Gc mutants migrated with a molecular weight that corresponds to the predicted weight of Gc dimers (.sup.˜100 kDa) (FIG. 5C).

(60) In the same way of example, the same approach was performed with double mutations of the Gn/Gc heterodimer interface; H294C/T734C; R281C/P748C; T99C/P774C; K85C/P774C and N94C/V776C. Under reducing conditions, the Gc mutants migrated at the wt Gc protein (.sup.˜50 kDa) while the Gn mutants migrated as the wt Gn protein (.sup.˜70 kDa) (FIG. 5D, lower panels). However, under non-reducing conditions, additional migration species were recognized by both, anti-Gn and anti-Gc antibodies, with a molecular weight of (.sup.˜130 kDa) that corresponds to the Gn/Gc heterodimer (FIG. 5D, upper panels).

(61) Together, in this example the inventors have shown that the cysteine substitution mutants at the Gc/Gc and Gn/Gc interface can be disulfide linked in a biological context, thereby forming Gc/Gc or Gn/Gc dimer linkage at the surface of viral particles. Hence, the residues forming the Gc dimer contacts in the X-ray structure of a pre-fusion form of Gc and the Gn/Gc contacts in the X-ray structure of the Gn/Gc heterodimer are proximal enough to each other on viral particles to allow for disulfide formation while still forming VLPs. This data also supports the biological relevance of the crystallographic structures proposed in Example 1 of this invention.

Example 4. Improved Acid Stability of the Hantaviral Spikes

(62) In this example, the inventors provide evidence, that bulky residue substitution at the Gc/Gc dimer interface can increase the resistance to different environmental factors, such as mild acidification. This is an import aspect since the administration of antigens to individual involves their suspension into immunologic adjuvants to improve immune responses. Yet, the most frequently used antigens, alum adjuvant in humans and Freund adjuvant in animals, have acidic pH that can perturb the antigen structure. This is of particular importance for the hantaviral spike, since already a mildly acidic pH activates the hantavirus Gc fusion protein inducing its non-infectious post-fusion conformation. Thus, in a preferred embodiment, it is desirable to improve the hantaviral spike stability not only in terms of their inter-chain contacts, but also in terms of their resistance to acidic pH.

(63) In this invention His residues were substituted since they are molecular sensors of mildly acidic pH, having an acid dissociation constant (plc) of .sup.˜6.0, coinciding with the pH range of Gc activation. In this context, the inventors have designed and characterized one Gc mutant in which they have substituted His953, located at the Gc homodimer interphase, to Phe (H953F) (FIG. 5A). To functionally assess its activation pH compared to wt Gn/Gc, we performed a liposome coflotation assay as a measure for activation by fusion loop exposure and membrane insertion established previously (Guardado-Calvo et al., 2016). Therefore we incubated VLPs bearing the wt or mutant spike H953F with fluorescently labeled liposomes at each pH and loaded the mixture to the bottom of a sucrose step gradient. After centrifugation, we monitored each fraction for the presence of liposomes (by fluorescence) and VLPs (by western blot against Gc). At pH 6.2, the liposomes migrated to the top of the gradient while the wild type VLPs remained in the bottom fractions (FIG. 4c and figure supplement 1a), but increasing amounts of the VLPs were observed in the top fractions at more acidic pHs. The inventors found that VLPs bearing the H953F spike mutant for pH-induced liposome coflotation was more resistant to activation, in a way that 50% activation occurred at pH 5.5 while the wt spike activation occurred already at pH 5.9 (FIG. 6). With the above techniques, those of skill in the art can routinely design other His substitutions or substitution of other protonable residues such as Asp and Glu at additional positions, and expect hantaviral spike resistance to mild acidification. Combinations of several His substitutions can lead to a still higher resistance to low pH and thus decrease perturbation of the hantaviral spikes when introduced into a pharmaceutical preparation.

(64) The inventors have shown in this example that it is possible to design residue substitutions that confer the hantaviral spikes a higher resistance to irreversible acid-induced activation that they can face in various environments.

Example 5. Improved Thermal Stability of the Hantaviral Spikes

(65) In order to favor conformations of the hantaviral spikes that correspond to their infectious arrangement, and in order to decrease the exposure of otherwise cryptic regions that may serve as a decoy for the immune system, the inventors subjected the diverse hantaviral spike mutants to temperature gradients in order to assess the melting temperature of each mutant.

(66) The inventors used blue-native polyacrylamide gel electrophoresis (BN PAGE) combined with its western blotting (native western blot) to compare the stability at increasing temperatures of the detergent-solubilized hantavirus wild type and mutant spike complexes. Previous to the characterization of specific hantaviral spike mutants, the properties of the wt spike had to be established. When we thus incubated VLPs bearing wt Gn/Gc spikes at neutral pH and 20° C., the detergent-solubilized spike was identified as a single band recognized by both, anti-Gn and anti-Gc MAbs (FIG. 7A, Gc WT 20° C.). This band migrated roughly as expected in BN-PAGE, given the migration of the individual Gn and Gc monomers (see migration at 50° C.), of the Gc postfusion homotrimer (see migration at acidic pH), and of the standard reference bands. When the wild type spike complex were treated at temperatures up to 50° C., the dissociation of the Gn/Gc spikes could be visualized on the gel by the gradual disappearance of the corresponding band and the concomitant appearance of faster migrating bands, which corresponded to several oligomeric Gn forms and to a monomeric Gc species (FIG. 7A, WT 40-50° C.). Quantification of the temperature-induced dissociation of the detergent solubilized wild type ANDV Gn/Gc spike revealed a melting temperature (Tm) of 37.7±0.4° C.

(67) By using this technique, the inventors characterized different hantaviral spike mutants, particularly those modifying the Gc/Gc homodimer contacts. Among those, we assessed the stability properties of the mutant G838C, in which we engineered a disulfide bond at the Gc dimer 2-fold axes, which thus revealed a strongly increased Tm of 48° C. (FIG. 7A, D). In this mutant spike, the Gc dissociation resulted in Gc migration species that did not dissociate at any tested condition, and the Gn/Gc complex dissociation resulted into (Gn/Gc).sub.2 heterodimers, Gn homooligomers and Gc homodimers. Thus, the higher Tm that we observed for G838C indicates that the Gc homodimer stabilizes not only the Gc homodimer interphase, instead it stabilizes the entire Gn/Gc spike. Hence, as for the wt spike, the dissociation of the Gc G838C homodimers leads to the disruption of the hantaviral spike. As a whole, our data indicates that the improvement of the Gc homodimer contacts at its 2-fold axis, strengthens the hantaviral spike structure as a whole.

(68) Another hantaviral spike mutant that the inventors characterized includes an inter-chain disulfide bond at the position H953 located at the interphase of the Gc homodimer by introducing the substitution H953C. Although this mutant forms disulfide linked Gc dimers (FIG. 5C), the inventors found that this Gc dimer mutant completely abrogated its simultaneous interaction with Gn since not Gn/Gc migration species of higher weight could be detected Thus, from this result it can be concluded that not any inter-chain disulfide bond at the Gc homodimer interphase leads to a concomitant improvement of the overall hantaviral spike stability and underlines the importance of this assay for the spike characterization.

(69) As negative controls, and to further include additional standards into this assay, we have also tested mutants from which we expected to weaken the Gc dimer contacts at its 2-fold axes. As expected, we could observe an opposite effect on the Gn/Gc spike stability, since the Tm decreased in all cases: Gc E677Q (Tm=35° C.), Gc D679S (Tm=34.5° C.) and Gc R951Q (Tm=32.3° C.). The decreased Tm of the mutants was accompanied by a concomitant decrease in their interactions energies, corroborating the role of the Gc homodimer in the stability of the Gn/Gc heterooligomers and confirming the role of these residues in the homodimeric Gc/Gc interactions.

(70) The inventors also assessed hantaviral spike complexes bearing the following double residue substitutions at the Gn/Gc interface; H294C/T734C and N94C/N776C. These mutants showed high molecular weight Gn/Gc migration species that did not dissociated up to high temperatures revealing highly increased Tm's of 79.1° C. and 60.4° C., respectively (FIG. 7B and FIG. 7E).

(71) As a whole, from this example it can be concluded that the introduction of the specific inter-chain disulfide bonds across the Gc/Gc interface located at the Gc homodimer 2-fold axes, (Gc G838) or at the Gn/Gc interface strongly increases the stability of the entire hantaviral spike. Those of skill in the art can perform similar analysis for other mutants and can expect to further improve the hantaviral spike stability by the introduction of residue modification that improve the contacts between Gn/Gc and Gn/Gn as described in Example 1. Combinations of different residue substitutions at different interphases of the hantaviral spike is likely to provide optimal spike stability.

(72) In a still wider context, hantaviral mutants bearing multiple residue substitutions, including those that increase the dissociation energy, for example by an inter-chain disulfide bond such as G838C, H294C/T734C or N94C/N776C combined with residue substitutions that improve the hantaviral spike resistance to low pH, such as H953F, can confer optimal spike stability.

Example 6. Restriction of Molecular Fluctuations in Hantaviral Spikes

(73) After having established how to assess and select stabilized Gc homodimers through disulfide bonds or by other residue substitutions (Examples 3-5), we also tested whether the hantaviral spike mutants induced a Gn/Gc conformation of lower flexibility concerning its molecular fluctuations. Therefore, we assessed whether the Gn/Gc heterooligomers expose transitorily the Gc fusion loops at physiological temperature (20 to 37° C., inside or outside a host cell, respectively). We further applied higher temperatures to measure whether the Gn/Gc dissociation into Gc monomers (FIG. 7) is related with the exposure of the Gc fusion loops. We measured the fusion loop exposure through their insertion into target membranes by the well-established liposome coflotation assay (Guardado-Calvo et al., 2016).

(74) When we thus incubated the wt hantaviral spikes assembled onto VLPs at neutral pH at low temperatures (20-30° C.), we observed the VLPs in the bottom fractions of the gradient (FIG. 8A), requiring as expected at these temperatures low pH for the conformational change that leads to target membrane insertion as described previously (Acuña et al., 2015; Guardado-Calvo et al., 2016). When we further increased the temperature to 37° C. and above, VLPs floated gradually with liposomes to the upper fractions, as temperature increased. To next determine whether membrane insertion at temperatures at 37° C. and above are specifically conducted by the Gc fusion loops or rather by unspecific interactions, we tested liposome coflotation of VLPs bearing the Gc mutant W766A/F900A. This Gc mutant includes two substitutions of the aromatic residues at the tip of the cd and be fusion loops to alanine, previously proven to be required for insertion into target membranes at low pH (Guardado et al., 2016). Thus, the heating to 50° C. at neutral pH of VLPs bearing this double fusion loop mutant, showed absence of liposome insertion (FIG. 8A), thereby proofing that exclusively the fusion loops are directly involved in membrane insertion at neutral pH. When we further compared the profiles of the VLP-liposome interaction with that of (Gn/Gc).sub.4 dissociation, we found that they coincide extremely well (FIG. 8B; T.sub.50%interaction=37.3° C.; Tm=36.3° C.), confirming that the temperature-induced dissociation of the Gn/Gc heterooligomers into Gc monomers is responsible for the exposure of the Gc fusion loops.

(75) After establishing the molecular fluctuations of the hantaviral spike in terms of its fusion loop exposure, we analyzed whether stabilized Gn/Gc mutants are more restricted in such fluctuations, providing additional information on the molecular structures that the antigen will adapt upon in vivo administration. By way of example, the inventors have characterized two Gc mutants to assess this. In the case of the stabilized hantaviral spike carrying the Gc G838C substitution including a disulfide bond at the Gc homodimer interphase, this mutant showed reduced fusion loop exposure at 50° C. compared to wt Gn/Gc (FIG. 8A), confirming thus a tighter association of the Gn/Gc complex.

(76) As a control, we also analyzed the inter-chain Gc disulfide bond mutant H953C that prevents the association of the Gc homodimers into Gn/Gc heterooligomers (FIG. 7A). Consisting with the previous results showing that heat-induced liposome insertion is dependent on the dissociation of the Gn/Gc spike complex, this mutant inserts readily into liposomes at any temperature, proofing the specificity of the assay (FIG. 8A).

(77) By using the technical approach of this example, those of skill in the art can perform similar analysis for other spike stabilizing mutants and can observe a decrease in the fluctuation of the spike.

(78) From these results it can be concluded the hantaviral spike complex exposes a high dynamic behavior at 37° C. and above, exposing internal regions that are not functionally involved in entry and act as a decoy to elicit antibodies that are not neutralizing. The design of stabilized Gn/Gc mutants will result in an increase the Gn/Gc dissociation energy in a way that conformational dynamics will be reduced. Thereby, the increase of the spike stability has a direct impact on the antigen presentation to the immune system of a host since it increases structures that are involved in a protective immune response through neutralizing antibodies and represses structures that are involved in the generation of non-neutralizing antibodies.

Example 7. Immune Responses the Hantaviral Spikes with Improved Stability and Antigenicity

(79) In this examples the inventors provide evidence, that the stabilization of the hantaviral spikes elicits higher neutralizing antibody titers that the wt spikes.

(80) To determine the efficacy of immune responses to wt or mutant hantaviral spikes, the inventors proceeded to assess the neutralizing antibody titers of animals which was each immunized with a different hantaviral spike mutant.

(81) In brief, 16 week old Balb/C mice were immunized intraperitoneal with 50 μg of antigen with incomplete Freund adjuvant on day 0 and immunizations repeated on days 7 and 14 with 50 μg of antigen mixed with complete Freund Adjuvant. On day 16 blood was extracted and used to analyze the neutralizing antibody titers. The following antigens were used for immunizations: VLPs bearing wt hantaviral spikes, stabilized VLPs bearing the single mutation G838C at the Gc homodimer interface and stabilized VLPs bearing the double mutation H294C/T734C at the Gn/Gc heterodimer interface.

(82) Neutralizing antibody titers of sera against Andes virus was assessed by incubation of Andes Orthohantavirus strain CHI-7913 with mice sera for 1 h and subsequent 1 h adsorption of the mixture to Vero E6 cells. As we established previously, using other cell entry inhibitors (Barriga et al., 2016), viral infection was allowed to proceed for 16 h to assess inhibition of the first round of infection. Next, cells were detached and the percentage of infected cells measured by cell cytometry using the anti-nucleoprotein MAb clone 7B3/F7. At a dilution of 1/500, the sera from mice immunized with VLPs bearing stabilized hantaviral spikes G838C showed 90% of viral inhibition while sera from mice immunized with wt VLPs only reduced infection by 45% (FIG. 9A). On the other hand, at a dilution of 1/500, the sera obtained from animals immunized with VLPs stabilized by double mutation H294V/T734C blocked viral infection by .sup.˜50% while in the same assay, sera from mice immunized with the wt VLPs achieved only 30% of inhibition (FIG. 9B).

(83) These results provide evidence that stabilized hantaviral spikes induce higher neutralizaing antibody responses in animals and hence have a huge potential to be used as improved immunogens or screening for binding of other viral inhibitors.

(84) TABLE-US-00001 SEQ ID NO: 1 MEGWYLVALGICYTLTLAMPKTTYELKMECPHTVGLGQGYIIGSTELGLI SIEAASDIKLESSCNFDLHTTSMAQKSFTQVEWRKKSDTTDTTNAASTTF EAQTKTVNLRGTCILAPELYDTLKKVKKTVLCYDLTCNQTHCQPTVYLIA PVLTCMSIRSCMARVFTSRIQVIYEKTHCVTGQLIEGQCFNPAHTLTLSQ PAHTYDTVTLPISCFFTPKESEQLKVIKTFEGILTKTGCTENALQGYYVC FLGSHSEPLIVPSLEDIRSAEVVSRMLVHPRGEDHDAIQNSQSHLRIVGP ITAKVPSTSSTDTLKGTAFAGVPMYSSLSTLVKNADPEFVFSPGIIPESN HSVCDKKTVPITWTGYLPISGEMEKVTGCTVFCTLAGPGASCEAYSENGI FNISSPTCLVNKVQRFRGSEQKINFICQRVDQDVVVYCNGQKKVILTKTL VIGQCIYTFTSLFSLMPDVAHSLAVELCVPGLHGWATVMLLSTFCFGWVL IPAVTLIILKCLRVLTFSCSHYTNESKFKFILEKVKVEYQKTMGSMVCDV CHHECETAKELESHRQSCINGQCPYCMTITEATESALQAHYSICKLTGRF QEALKKSLKKPEVKKGCYRTLGVFRYKSRCYVGLVWCLLLTCEIVIWAAS AETPLMESGWSDTAHGVGEIPMKTDLELDFSLPSSSSYSYRRKLTNPANK EESISFHFQMEKQVIHAEIQPLGHWMDATFNTKTAFHCYGACQKYSYPWQ TSKCFFEKDYQYETGWGCNPGDCPGVGTGCTACGVYLDKLKSVGKAYKII SLKYTRKVCIQLGTEQTCKHIDANDCLVTPSVKVCIVGTVSKLQPSDTLL FLGPLEQGGVILKQWCTTSCAFGDPGDIMSTPSGMRCPEHTGSFRKICGF ATTPVCEYQGNTISGYKRMMATKDSFQSFNLTEPHITANKLEWIDPDGNT RDHVNLVLNRDVSFQDLSDNPCKVDLHTQAIEGAWGSGVGFTLTCTVGLT ECPSFMTSIKACDLAMCYGSTVANLARGSNTVKVVGKGGHSGSSFKCCHD TDCSSEGLLASAPHLERVTGFNQIDSDKVYDDGAPPCTFKCWFTKSGEWL LGILNGNWIVVVVLVVILILSIIMFSVLCPRRGHKKTV

REFERENCES

(85) Cifuentes-Muñoz N, Darlix I L, Tischler N D. Development of a lentiviral vector system to study the role of the Andes virus glycoproteins. Virus Res. 2010; 153(1):29-35. doi: 10.1016/j.virusres.2010.07.001. Guardado-Calvo P, Bignon E A, Stettner E, Jeffers S A, Pérez-Vargas J, Pehau-Arnaudet G, Tortorici M A, Jestin J L, England P, Tischler N D, Rey F A. Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein Gc. PLoS Pathog. 2016; 12(10):e1005813. doi: 10.1371/journal.ppat.1005813. PMID: 27783711 Hardestam J, Simon M, Hedlund K O, Vaheri A, Klingström J, Lundkvist A. Ex vivo stability of the rodent-borne Hantaan virus in comparison to that of arthropod-borne members of the Bunyaviridae family. Appl Environ Microbiol. 2007; 73(8):2547-51. doi: 10.1128/AEM.02869-06. PMID: 17337567 Harrison S C. Viral membrane fusion. Virology 2015; 0:498-507. doi:10.1016/j.virol.2015.03.043. Hepojoki J, Strandin T, Vaheri A, Lankinen H. Interactions and oligomerization of hantavirus glycoproteins. J Virol. 2010; 84(1):227-42. doi: 10.1128/JVI.00481-09. Huiskonen J T, Hepojoki J, Laurinmaki P, Vaheri A, Lankinen H, Butcher S J, et al. Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol. 2010; 84(10):4889±97. doi: 10.1128/JVI.00057-10 PMID: 20219926 Kleinfelter L M, Jangra R K, Jae L T, Herbert A S, Mittler E, Stiles K M, Wirchnianski A S, Kielian M, Brummelkamp T R, Dye J M, Chandran K. Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion. MBio. 2015 Jun. 30; 6(4):e00801. doi: 10.1128/mBio.00801-15. Li S, Rissanen I, Zeltina A, Hepojoki J, Raghwani J, Harlos K, Pybus O G, Huiskonen J T, Bowden T A. A Molecular-Level Account of the Antigenic Hantaviral Surface. Cell Rep. 2016; 16(1):278. doi: 10.1016/j.celrep.2016.06.039. PMID: 27355863 NIH, 2016: https://www.niaid.nih.gov/research/emerging-infectious-diseases-pathogens Ray N, Whidby J, Stewart S, Hooper J W, Bertolotti-Ciarlet A. Study of Andes virus entry and neutralization using a pseudovirion system. J Virol Methods 2010; 163(2):416-23. doi: 10.1016/j.jviromet.2009.11.004. Epub 2009 Nov. 10. Rey, F A, Lok, S M. Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines. Cell 2018; 172 (6), 1319-1334. Boudreau E F, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper J W. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. Vaccine 2012; 30(11):1951-8. doi: 10.1016/j.vaccine.2012.01.024. Barriga G P, Villalón-Letelier F, Márquez CL, Bignon E A, Acuña R, Ross B H, Monasterio O, Mardones G A, Vidal S E, Tischler N D. Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc. PLoS Negl Trop Dis. 2016; 10(7):e0004799. doi: 10.1371/journal.pntd.0004799. Vial P A, Valdivieso F, Calvo M, Rioseco M L, Riquelme R, Araneda A, Tomicic V, Graf J, Paredes L, Florenzano M, Bidart T, Cuiza A, Marco C, Hjelle B, Ye C, Hanfelt-Goade D, Vial C, Rivera J C, Delgado I, Mertz G J; Hantavirus Study Group in Chile. A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus. Antivir Ther. 2015; 20(4):377-86. doi: 10.3851/IMP2875. Maes P, Clement J, Van Ranst M. Recent approaches in hantavirus vaccine development. Expert Rev Vaccines 2009; 8(1):67-76. doi: 10.1586/14760584.8.1.67.